ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Pain Treatment Guide Published By NCCN, ACS

April 27, 2001

Regions Outlined In CIS Proposal

May 31, 1991

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

NCI Details How Year 2000 Goals Can Be Reached Bypass Budget Spells Out How Much It Will Cost

June 8, 1984